Does the AT2-receptor mediate anti-atherosclerotic actions?

J Hypertens. 2005 Aug;23(8):1469-70. doi: 10.1097/01.hjh.0000174611.49274.1e.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Angiotensin II / pharmacology*
  • Animals
  • Apolipoproteins / deficiency*
  • Apolipoproteins / genetics
  • Apolipoproteins / physiology
  • Arteriosclerosis / etiology*
  • Arteriosclerosis / metabolism*
  • Blood Pressure
  • Cholesterol, Dietary / pharmacology
  • Imidazoles / pharmacology
  • Male
  • Mice
  • Mice, Knockout
  • Pyridines / pharmacology
  • Receptor, Angiotensin, Type 2 / genetics
  • Receptor, Angiotensin, Type 2 / metabolism*
  • Vasoconstrictor Agents / pharmacology

Substances

  • Apolipoproteins
  • Cholesterol, Dietary
  • Imidazoles
  • Pyridines
  • Receptor, Angiotensin, Type 2
  • Vasoconstrictor Agents
  • Angiotensin II
  • PD 123319